Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2016  |  Volume : 12  |  Issue : 2  |  Page : 798-804

Treatment of undifferentiated colorectal cancer cells with fish-oil derived docosahexaenoic acid triggers caspase-3 activation and apoptosis


1 Department of Histology and Embryology, Faculty of Science; Department of Cellular and Molecular Biotechnology, Institute of Biotechnology, Urmia, Iran
2 Department of Histology and Embryology, Faculty of Science; Department of Cellular and Molecular Biotechnology, Institute of Biotechnology; Royan Stem Cell Technology Company, West Azarbaijan Cord Blood Bank, Urmia, Iran
3 Department of Histology and Embryology, Faculty of Science, Institute of Biotechnology, Urmia, Iran
4 Department of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

Correspondence Address:
Mohammad Reza Sam
Institute of Biotechnology, Urmia University, P.O.Box: 165, Urmia
Iran
Login to access the Email id

Source of Support: The sources of financial support were National Cell Bank of Iran (NCBI), Pasture Institute of Iran and Urmia University, Conflict of Interest: None


DOI: 10.4103/0973-1482.157326

Rights and Permissions

Background: The effectiveness of chemotherapy is often limited by the side effects on normal tissues. Consequently, the search for new therapeutic agents with minimal toxicity is of particular interest in cancer management. Many studies have shown that docosahexaenoic acid (DHA) have cytotoxic effects against different kinds of cancer cells. However, little attention has been paid to explore the effect of DHA on undifferentiated colorectal cancer cells. In this study, the effects of DHA on LS174T cells as an early stage of tumor initiation were investigated. Materials and Methods: Tumor cells were treated to various concentrations of DHA and proliferation, survivin expression, caspase-3 activation, and apoptosis were evaluated by different cellular and molecular techniques. Results: Following 48 h treatment, proliferation was measured to be 73 ± 4.5% (P = 0.000), 53 ± 5.7% (P = 0.000) and 26.3 ± 3.5% (P = 0.000) for 50, 100, and 150 µM DHA, respectively compared to untreated cells. This molecule induced 63% (P = 0.001) and 46% (P = 0.000) decrease in survivin messenger ribonucleic acid (mRNA) level as well as 1.8 (P = 0.001) and three-fold (P = 0.000) increase in caspase-3 activation for 50 and 100 µM DHA, respectively compared to untreated cells. Our evidence showed that survivin mRNA is expressed at the early stage of colorectal cancer cells and DHA-treated cells expressed markedly a lower survivin mRNA compared to untreated cells. Conclusions: DHA is an attractive repressor of survivin expression, increases caspase-3 and apoptosis in colorectal cancer cells and may provide a novel approach to the treatment of colorectal cancer at the early stage of tumor initiation.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1755    
    Printed18    
    Emailed0    
    PDF Downloaded118    
    Comments [Add]    

Recommend this journal